about
Pathogenesis of osteoporosis: concepts, conflicts, and prospectsPreventive health measures in inflammatory bowel diseaseFractal lacunarity of trabecular bone and magnetic resonance imaging: New perspectives for osteoporotic fracture risk assessmentFoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblastsOsteoporosis: "A risk factor for periodontitis"Assessing forearm fracture risk in postmenopausal womenAnamnestic risk factor questionnaire as reliable diagnostic instrument for osteoporosis (reduced bone morphogenic density).Comparing the T scores from bone sonometer measurements in Hispanic and non-Hispanic white women.Basic and clinical aspects of osteoporosis in inflammatory bowel disease.Low back pain investigations and prognosis: a reviewWhat accounts for rib fractures in older adults?Association of hip strength estimates by finite-element analysis with fractures in women and menAge at First Delivery and Osteoporosis Risk in Korean Postmenopausal Women: The 2008-2011 Korea National Health and Nutrition Examination Survey (KNHANES).Improving care of patients at-risk for osteoporosis: a randomized controlled trialSimultaneous screening for osteoporosis at CT colonography: bone mineral density assessment using MDCT attenuation techniques compared with the DXA reference standard.Interaction between bone and muscle in older persons with mobility limitationsHypercholesterolemia promotes an osteoporotic phenotype.Association between gait speed and bone strength in community-dwelling postmenopausal Japanese women.IBD and skeletal health: children are not small adults!Prevention and treatment of osteoporosis in inflammatory bowel disease.Osteoporosis and periodontal disease.Review of postmenopausal osteoporosis pharmacotherapy.Evaluation of persistence and adherence to teriparatide treatment in patients affected by severe osteoporosis (PATT): a multicenter observational real life study.Bone mineral density scans in veteransOpportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications.Changes in Nonosteoporotic Bone Density and Subsequent Fractures in WomenScreening bone mineral density in epilepsy: a call to action, but what action?Osteoporosis risk prediction for bone mineral density assessment of postmenopausal women using machine learningAssociation of coronary artery and aortic calcium with lumbar bone density: the MESA Abdominal Aortic Calcium Study.Relation Between Hepatitis C Virus Exposure and Risk of Osteoporosis: A Nationwide Population-Based Study.Fighting the fracture cascade: evaluation and management of osteoporotic fractures.The osteoporosis revolution marches on.General health maintenance in IBD.Prevention, screening, and management of osteoporosis: an overview of the current strategies.Utility of C-terminal Telopeptide in Evaluating Levothyroxine Replacement Therapy-Induced Bone Loss.Serum osteoprotegerin concentration with strontium ranelate treatment for postmenopausal osteoporosis: an open, prospective study.Type 1 diabetes and osteoporosis: A review of literatureBeneficial Effect of Oral Bisphosphonate Treatment on Bone Loss Induced by Chronic Administration of Furosemide without Alteration of Its Administration and Urinary Calcium Loss.Treatment of elderly patients with stage IV non-small-cell lung cancer.Bone, sweet bone--osteoporotic fractures in diabetes mellitus.
P2860
Q24536164-F0D83B9B-9A3E-4361-875A-445839822A99Q28078112-DA4A00E4-845C-48F1-953E-5F798A1AF46BQ28081908-B07B5FB7-0220-43DA-BFA5-EEB25EF539CDQ33646924-24C1CCE9-2EE6-4CD2-B5D4-8D8291224E1CQ33759893-609FD8D2-06C9-4544-A2C9-EF378D40935DQ33926919-3F78DC2D-915D-401E-89AA-43055DB85458Q33995108-16F32A00-FEA5-40DB-9F82-ECED54C72632Q34138805-94F6C303-45C8-4D16-9B4C-E1B5E206EFD6Q34225188-8A870A4C-4EDB-4CE8-8F7F-2F11FB04FCF5Q34567770-9EB6A153-FE28-4FB5-B72C-EB68CA3E2775Q35418396-F18229ED-742A-4D7B-B6A5-E591BA94B826Q35446629-5FAC54A8-B8AF-4411-BEA3-7CED6FD9F355Q35577552-B9976AC9-F8BF-4AB3-89ED-DAC24190EC0BQ35683269-982669CF-CCA4-4D7A-B0FB-2DD2EE9E6EB0Q35832441-B2086544-BF3A-4FE6-A228-B442733B16BDQ36100758-82C35A39-8D41-4198-A953-466D295B5EFEQ36204181-F5B47C2F-84E8-4490-AF77-61ADFD8DCA5FQ36219866-D2F4DC89-E560-4DCE-AB03-5CB493E4D593Q36292836-7BC80EA7-539E-4D43-8CD3-9DBDE1B9A421Q36569260-FAA21F9C-7914-495A-861F-3A640AA2731BQ36809161-C875DDB0-350E-4A4A-AFEC-B86C224C2FF2Q36824453-6C972CF9-C954-40B3-8E0D-935D2D628928Q37008062-8B0DC706-7BF5-4D04-9542-28D731A53971Q37017411-7353F4FA-4362-40AD-92BE-92768D25DD09Q37078753-81FEF272-2952-4EEF-8A74-E3A8354CA3D7Q37163823-67A53AA8-738E-41F1-8A86-560C8D8AE373Q37169769-71A63B86-F77C-469D-A811-4AA3C3C1A46FQ37259537-7DF032E3-D578-4E5C-A0A6-68F05C9CF530Q37306185-E231836F-8180-4CA8-BC62-12669D8D004CQ37328614-6E741100-43F2-46E0-BD11-7EE2642276C9Q37329886-A1144F93-578A-40B7-8088-F0344E3077AEQ37426033-3F57FA74-A6B4-46B6-A57C-EE6CE0B2CD4CQ37547079-D8326012-868C-4614-9F05-4A06F30E83D4Q37566044-C38ABE85-36C6-4162-A3C5-33B7585498D1Q37628696-17668B80-A6C8-4A7B-9540-9CF1414F4B5CQ37667201-27B54186-36A6-48CB-9F1F-2014E5C43401Q37703685-D917B865-B3E4-4A73-8FA2-AD0F530D97E2Q37732700-48E6CB65-1EEF-42D5-BD53-49A41E464DD0Q37965641-07BF9291-C4A4-4040-A346-C5530B7A5E3EQ37976305-D56025F9-1027-4CEB-93ED-A5C95BA1EEEF
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Clinical practice. Screening for osteoporosis.
@ast
Clinical practice. Screening for osteoporosis.
@en
type
label
Clinical practice. Screening for osteoporosis.
@ast
Clinical practice. Screening for osteoporosis.
@en
prefLabel
Clinical practice. Screening for osteoporosis.
@ast
Clinical practice. Screening for osteoporosis.
@en
P356
P1476
Clinical practice. Screening for osteoporosis.
@en
P2093
Lawrence G Raisz
P304
P356
10.1056/NEJMCP042092
P407
P577
2005-07-01T00:00:00Z